302 related articles for article (PubMed ID: 33670217)
41. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
[TBL] [Abstract][Full Text] [Related]
42. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
[TBL] [Abstract][Full Text] [Related]
43. [In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].
Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Mazurkova NA; Sergeev AA; Serova OA; Stavskiĭ EA; Drozdov IG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):93-6. PubMed ID: 21598625
[TBL] [Abstract][Full Text] [Related]
44. Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds.
Torres E; Duque MD; Vanderlinden E; Ma C; Pinto LH; Camps P; Froeyen M; Vázquez S; Naesens L
Antiviral Res; 2013 Sep; 99(3):281-91. PubMed ID: 23800838
[TBL] [Abstract][Full Text] [Related]
45. Anti-influenza activity of Alchemilla mollis extract: possible virucidal activity against influenza virus particles.
Makau JN; Watanabe K; Kobayashi N
Drug Discov Ther; 2013 Oct; 7(5):189-95. PubMed ID: 24270383
[TBL] [Abstract][Full Text] [Related]
46. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.
Little K; Leang SK; Butler J; Baas C; Harrower B; Mosse J; Barr IG; Hurt AC
Euro Surveill; 2015; 20(45):. PubMed ID: 26608955
[TBL] [Abstract][Full Text] [Related]
47. Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ.
Hu XP; Shao MM; Song X; Wu XL; Qi L; Zheng K; Fan L; Liao CH; Li CY; He J; Hu YJ; Wu HQ; Li SH; Zhang J; Zhang FX; He ZD
J Ethnopharmacol; 2016 Feb; 179():128-36. PubMed ID: 26190352
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.
Xiang D; Zheng Y; Duan W; Li X; Yin J; Shigdar S; O'Connor ML; Marappan M; Zhao X; Miao Y; Xiang B; Zheng C
Int J Nanomedicine; 2013; 8():4103-13. PubMed ID: 24204140
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effect of 2,4-dichlorophenoxyacetic acid on ROS, autophagy formation, and mRNA replication for influenza virus infection.
Enkhtaivan G; Muthuraman P; Kim DH
J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28233349
[TBL] [Abstract][Full Text] [Related]
50. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
[TBL] [Abstract][Full Text] [Related]
51. Phosphatidylglycerol suppresses influenza A virus infection.
Numata M; Kandasamy P; Nagashima Y; Posey J; Hartshorn K; Woodland D; Voelker DR
Am J Respir Cell Mol Biol; 2012 Apr; 46(4):479-87. PubMed ID: 22052877
[TBL] [Abstract][Full Text] [Related]
52. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
53. Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs.
Jin J; Chen S; Wang D; Chen Y; Wang Y; Guo M; Zhou C; Dou J
Biomed Pharmacother; 2018 Jan; 97():385-394. PubMed ID: 29091888
[TBL] [Abstract][Full Text] [Related]
54. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo.
Li Z; Zhao J; Zhou H; Li L; Ding Y; Li J; Zhou B; Jiang H; Zhong N; Hu W; Yang Z
Life Sci; 2018 May; 200():115-125. PubMed ID: 29555588
[TBL] [Abstract][Full Text] [Related]
55. Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture.
Selvam P; Chandramohan M; Hurst BL; Smee DF
Antivir Chem Chemother; 2010 Jan; 20(3):143-6. PubMed ID: 20054101
[TBL] [Abstract][Full Text] [Related]
56. Ceramide Suppresses Influenza A Virus Replication
Soudani N; Hage-Sleiman R; Karam W; Dbaibo G; Zaraket H
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700605
[TBL] [Abstract][Full Text] [Related]
57. Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.
Maddry JA; Chen X; Jonsson CB; Ananthan S; Hobrath J; Smee DF; Noah JW; Noah D; Xu X; Jia F; Maddox C; Sosa MI; White EL; Severson WE
J Biomol Screen; 2011 Jan; 16(1):73-81. PubMed ID: 21059874
[TBL] [Abstract][Full Text] [Related]
58. Cryptoporus volvatus extract inhibits influenza virus replication in vitro and in vivo.
Gao L; Sun Y; Si J; Liu J; Sun G; Sun X; Cao L
PLoS One; 2014; 9(12):e113604. PubMed ID: 25437846
[TBL] [Abstract][Full Text] [Related]
59. Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract.
Glatthaar-Saalmüller B; Fal AM; Schönknecht K; Conrad F; Sievers H; Saalmüller A
Phytomedicine; 2015 Sep; 22(10):911-20. PubMed ID: 26321740
[TBL] [Abstract][Full Text] [Related]
60. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
